Experimental Alzheimer's Drug That Fights a Tough-to-Target Protein Shows Promise at Slowing Cognitive Decline in a Clinical Trial

Recently FDA-approved treatments work to clear clumps of the protein amyloid beta in the brain.

Continue in Briflio to read, react, comment, and share.